Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Neurobiol Aging. 2016 Apr 4;44:1–8. doi: 10.1016/j.neurobiolaging.2016.03.025

Table 3.

Overlap in preclinical AD classification based on CSF and imaging biomarkers

CSF biomarkers
Normal N=127 Stage 1N=26 Stage 2+N=19 SNAP N=40
Imaging biomarkers Normal 79 (62%) 10 (39%) 2 (11%) 23 (58%)
Stage 1 9 (7%) 11 (42%) 14 (74%) 8 (20%)
Stage 2+ 5 (4%) 5 (19%) 3 (16%) 3 (8%)
SNAP 34 (27%) - - 6 (15%)

Results are number (%) of subjects in the classification groups based on CSF classification. CSF=cerebrospinal fluid; SNAP=suspected non-Alzheimer pathophysiology.